Navigation Links
California Stem Cell Agency Exaggerated Its Role in Funding Key Research
Date:4/16/2008

Agency Claimed State Funding Led to Important Clinical Trials

SANTA MONICA, Calif., April 16 /PRNewswire-USNewswire/ -- California's stem cell agency overstated and hyped the importance of its funding in enabling clinical trials for a drug to treat a severe blood disorder, Consumer Watchdog said today, seriously undercutting the agency's credibility and alienating those who support publicly funded stem cell research.

Last week the California Institute For Regenerative Medicine (CIRM) issued a news release titled "First Clinical Trial Begins for a Therapy Enabled By CIRM Funding." The announcement even drew a comment from Gov. Arnold Schwarzenegger, who issued a release saying CIRM funding led to the discovery. He added, "I am proud of our state's commitment to stem cell research, which delivers the best promise in finding treatments for deadly and debilitating diseases."

A report on today's California Stem Cell Report published by David Jensen makes clear how little CIRM funding was actually involved in the research by a team led by UCSD's Catriona Jamieson.

"There is important scientific work here that led quickly to an important clinical trial," said John M. Simpson, director of Consumer Watchdog's Stem Cell Project. "But the fact is that CIRM is jumping on the bandwagon claiming credit for contributions that were at best rather trivial."

The initial CIRM news release about the clinical trial said that Jamieson was funded by a stem cell SEED grant that was approved in February 2007. That grant was given to fund the derivation of cancer-causing stem cells from human embryonic stem cells. The research that led to the clinical trial did not involve human embryonic stem cells at all.

Moreover, according to the official notice of grant award, the time period for the CIRM funded grant of $613,305 was from Aug. 1, 2007- July 31, 2009. The university officially signed off on the grant on Aug. 31, 2007. The paper outlining the research findings was submitted to "Cancer Cell" on Sept. 19, 2007.

Read the notice of grant award here: http://www.consumerwatchdog.org/resources/Noticeofgrant.pdf

"CIRM is too eager to claim immediate results," said Simpson. "Certainly we'll see great benefit as the result of stem cell research, but this political manipulation and hype does a tremendous disservice to all who believe in the value of this research."

After Jensen asked questions about the CIRM release, the agency modified the version posted on its website to note that an earlier CIRM training grant had gone to pay the salary of a post doctoral researcher in Jamieson's laboratory.

"Stem cell agency officials repeatedly say, 'It's all about the science,'" said Simpson. "If only that were true. More often than not -- as in this case -- it's all about appearances, hype and claiming credit."

Proposition 71 that created CIRM passed by 59 percent of Californians voting in 2004. Consumer Watchdog's Stem Cell Oversight and Accountability Project is working to ensure that California's landmark stem cell research program offers accessible and affordable cures and treatments to the taxpayers who have funded it. The program will sell $3 billion in bonds over a decade to fund stem cell research. Financing charges mean the project, the largest source of stem cell research funding in the world, will cost California taxpayers $6 billion.

Consumer Watchdog, formerly the Foundation for Taxpayer and Consumer Rights, is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org.


'/>"/>
SOURCE Consumer Watchdog
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
2. New Conflict of Interest Violations Revealed at California Stem Cell Institute
3. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
4. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
5. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
6. Saving Lives of California Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
7. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
8. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
9. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
10. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
11. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb. 8, 2016 CBG ... the PW Series Solvent Recycling Systems, specifically designed ... full integration with new and existing vapor degreasers, ... produces consistently-fresh solvent through continuous recycling and recovers ... --> --> Precision parts ...
(Date:2/8/2016)... 2016 --> ... "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, ... Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020", published ... the forecast period of 2015 to 2020. The market ... CAGR of 10.5% from 2015 to 2020. ...
(Date:2/8/2016)... EAST NORRITON, Pa. , Feb. 8, 2016 ... acquisition of November Research Group (NRG),s pharmacovigilance ... of pharmacovigilance system-related consulting services and an Oracle ... regulatory compliance services to Life Sciences companies. ... acquisition strengthens and expands HighPoint,s life sciences capabilities ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... February 09, 2016 , ... Shark Finds and Kevin Harrington, and the Product Managers ... , GRIP-DRY is a newly patented product that has solved some of the basic problems ... and early morning dew or right after a rain shower, might understand the struggle of ...
(Date:2/8/2016)... ... February 08, 2016 , ... CURE Media Group , the nation’s ... Multiple Myeloma Heroes Awards event , which will annually honor individuals making heroic ... with MM. The MM Heroes Awards nomination process is officially open through ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenntag Specialties, Inc.(BSI) , ... Food & Beverage and Dietary Supplement market segments across the ... USA geographies east of the Rocky Mountains since 2012. Consistent performance in ...
(Date:2/8/2016)... ... 08, 2016 , ... Stephanie Hebert Insurance Agency, serving families ... new charity campaign. As part of their ongoing community involvement program, funds are ... that children deserve a voice, and in the spirit of neighbors helping neighbors ...
(Date:2/8/2016)... Angeles, CA (PRWEB) , ... February 08, 2016 , ... A man who has struggled ... of Freedom Laser Therapy , was determined to find solutions to his problems – ... of Inventors Digest is ready to introduce his breakthrough inventions to the world ...
Breaking Medicine News(10 mins):